Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Regulatory clarity for market evolution: Canada’s position in global crypto industry

By Shaed Hashimkhial Canada is a forefront contender in financial innovation and cryptocurrency, with significant potential to dominate the digital asset sector. However, opinions vary within the industry; some advocate for clear legislation to support growth, whil...

Desert Gold, Barrick, Intel: Will U.S. stagflation push gold higher?

Gold has reached another record level of over US$2,300 per ounce. Investors are betting that the U.S. Federal Reserve will cut interest rates later this year. Gold has been on an upward trend since mid-February. On the one hand, it has a reputation for maintaining or...

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Buzz on the Bullboards: Who is shining through the market slump?

The market story this week has been less impressive on both sides of the border than what we saw in the week where February turned to March. Recent losses and flatline trading have negated Wall Street’s previous record-setting run where major U.S. indices ...

IoT solutions company raises cleaning standards

The following is a transcription of the above video, and The Market Online Canada has edited it for clarity . Our next company is Visionstate Corp. (TSXV:VIS) , headquartered in Edmonton. The company is focused on delivering data-driven, innovative and sustainable ...

Buzz on the Bullboards: Upbeat U.S. earnings good news for all?

Do rising tides truly lift all ships? We are in the midst of a strong earnings season and U.S. markets have reacted in kind. Strong earnings growth pushed Wall Street indices towards fresh record highs this past week. While activity moved lower earlier on, the belief ...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...
1 2 3 4 5 6 7 8 9 10 ...